Gene · 9780
NIH grants1,590
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,590
Download this page as JSON| Grant | Title | PIEZO1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI167933 | Regulation of IgE and Atopic Itch | 1 | 2025 |
| R01AI169687 | Transcriptional and metabolomic regulation of IL-10 in pulmonary ILC2s | 1 | 2025 |
| R01AI172873 | Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS | 1 | 2025 |
| R01AI173050 | Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies | 1 | 2025 |
| R01AR041836 | Function of Desmoglein 1/Pemphigus Foliaceus Antigen | 1 | 2025 |
| R01AR047867 | Response of the Osteoporotic Skeleton to Mechanical Loading | 1 | 2025 |
| R01AR064327 | Reprogramming and Directed Differentiation of Skeletal Muscle Cells from hPSCs | 1 | 2025 |
| R01AR071435 | Transcriptional regulation of skin stem cells and their niche | 1 | 2025 |
| R01AR077007 | Natural Killer Cell Regulation of Skin Inflammation | 1 | 2025 |
| R01AR080127 | Mechano signals regulating tendon and ligament homeostasis | 1 | 2025 |
| R01AR082973 | Contribution of the NOD/RIPK2 signaling pathway to osteoarthritis susceptibility | 1 | 2025 |
| R01CA124704 | Tubulin microtentacles in detached mammary epithelial cells | 1 | 2025 |
| R01CA160069 | Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver | 1 | 2025 |
| R01CA174869 | Regulation of Tumor Invasion and Metastasis by Matrix Stiffness | 1 | 2025 |
| R01CA216101 | Mitochondrial Regulation of Antitumor Immunity | 1 | 2025 |
| R01CA221346 | Microfluidic platform for solid tumor mechanics and invasion | 1 | 2025 |
| R01CA227942 | Targeting the cancer glycocalyx | 1 | 2025 |
| R01CA240965 | The role of multi-cellular aggregates vs. individual tumor cells in metastasis of high-grade serous ovarian cancer | 1 | 2025 |
| R01CA250557 | Imaging Modulation of Immune Phenotype | 1 | 2025 |
| R01CA258384 | Neuronal Regulation of Low-Grade Gliomagenesis | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9780/grants?page=9